GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BioLineRx BLRX · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.58

-7.60%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on BioLineRx

Our reporting

We have not reported on BioLineRx yet.

Next results

23 Nov 2026

Due on 23 Nov 2026. Analysts expect earnings of -0.39 a share on revenue of $357,500.

Past results

Reported against what analysts expected

31 Aug 202613 Aug 202627 May 202623 Mar 202624 Nov 202514 Aug 2025
Earnings per share-0.771.00-0.58-0.34-0.22-1.00
Forecast-0.150.00-1.04-0.50-0.41-0.35
Revenue$294,000—$477,000$194,000$427,000$304,000
Forecast$500,000—$343,000$514,000$990,000$661,333

Key events

  1. 30 Jan 202540-to-1 reverse split
  2. 15 Jul 201915-to-1 reverse split
  3. 25 Jul 2011Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.